Path analysis of biomarkers for cognitive decline in early Parkinson's disease.

Path analysis of biomarkers for cognitive decline in early Parkinson's disease.

Show other versions (1)

Clinical and biochemical diversity of Parkinson's disease (PD) and numerous demographic, clinical, and pathological measures influencing cognitive function and its decline in PD create problems with the determination of effects of individual measures on cognition in PD. This is particularly the...

Full description

Bibliographic Details
Main Authors: Dmitri K Gramotnev, Galina Gramotnev, Alexandra Gramotnev, Mathew J Summers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0268379

Similar Items

Similar Items